Graham Corp
3 nominees · 3 ballot items.
Election of three director nominees; advisory vote on the compensation of our named executive officers; and ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the 2026 fiscal year.
Follow how the vote landed and what changed on Graham Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of three director nominees
ManagementBoard: FORElection of Cari L. Jaroslawsky, Matthew J. Malone and Jonathan W. Painter to serve as Graham Corporation directors for a three-year term.
- 2
Advisory Vote on the Compensation of Our Named Executive Officers
ManagementBoard: FORNon-binding advisory vote to approve the compensation of our named executive officers as disclosed in this proxy statement.
- 3
Ratification of the Appointment of Deloitte & Touche LLP as Our Independent Registered Public Accounting Firm
ManagementBoard: FORRatify Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2026.
Nominees on the ballot3
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BRANDES INVESTMENT PARTNERS, LP | 8.2% | 960,603 | $76M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 453,812 | $36M |
| 3 | ROYCE ASSOCIATES LP | 3.8% | 448,758 | $35M |
| 4 | BlackRock, Inc. | 3.3% | 388,048 | $31M |
| 5 | DRIEHAUS CAPITAL MANAGEMENT LLC | 2.9% | 342,908 | $27M |
| 6 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.7% | 314,301 | $25M |
| 7 | BlackRock, Inc. | 2.5% | 289,220 | $23M |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 2.1% | 247,368 | $20M |
| 9 | GAMCO INVESTORS, INC. ET AL | 2.1% | 243,907 | $19M |
| 10 | First Eagle Investment Management, LLC | 1.8% | 215,513 | $17M |
Other Industrials sector meetings6
Upcoming shareholder meetings at Graham Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Graham Corp 2025 annual meeting?
- Graham Corp (GHM) holds its 2025 annual shareholder meeting on Tuesday, August 26, 2025.
- What is the record date for the Graham Corp 2025 meeting?
- The record date for the Graham Corp 2025 meeting is Friday, June 27, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Graham Corp's 2025 meeting?
- The board is presenting 3 director nominees at the Graham Corp 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Graham Corp 2025 meeting?
- Shareholders will vote on 3 proposals at the Graham Corp 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.